Infectious Disease and Microbiology – Sphingobacterium Species

Overview

Sphingobacterium species are uncommon aerobic Gram-negative bacilli that are widely distributed in the environment but only rarely cause human disease. Important species include Sphingobacterium multivorum and Sphingobacterium spiritivorum.

Human infections are usually opportunistic and healthcare-associated, particularly in patients with significant underlying disease, immunocompromise, prolonged hospitalization, or invasive medical devices. Reported infections include bacteremia, peritonitis, pneumonia and other respiratory infections, urinary tract infections, and skin and soft-tissue infections.

Classification

Genus: Sphingobacterium

Important species include:

• Sphingobacterium multivorum

• Sphingobacterium spiritivorum

• Other Sphingobacterium species

Microbiologic Characteristics

Sphingobacterium species are:

• Aerobic Gram-negative bacilli

• Nonfermenting organisms

• Generally nonmotile

• Environmental bacteria

• Uncommon human pathogens

A distinctive feature of the genus is the presence of:

Sphingolipids within the bacterial cell membrane

which contributed to the name:

Sphingobacterium

High-Yield Microbiology Pattern

Aerobic Gram-negative bacillus

• ●

Nonfermenting environmental organism

• ●

Sphingolipids in cell membrane

• ●

Rare healthcare-associated infection

→ Think Sphingobacterium

Incubation Period

The incubation period is:

Unknown

Because most infections are opportunistic or healthcare-associated, there is no characteristic incubation period.

Epidemiology

Sphingobacterium species have a:

Worldwide distribution

However, human infections are:

Rare

The organisms can be encountered in environmental reservoirs, including:

• Soil

• Water

• Plants

• Moist environmental sites

Nosocomial Infection

The source emphasizes that Sphingobacterium species usually cause:

NOSOCOMIAL INFECTIONS

Healthcare-associated disease may be facilitated by:

• Prolonged hospitalization

• Critical illness

• Immunosuppression

• Invasive medical procedures

• Indwelling catheters

• Significant underlying disease

• Previous broad-spectrum antimicrobial exposure

High-Yield Epidemiologic Pattern

Hospitalized or medically complex patient

• ●

Unusual nonfermenting Gram-negative bacillus

• ●

Bacteremia, respiratory infection, or device-associated infection

→ Consider Sphingobacterium

Opportunistic Pathogenicity

Sphingobacterium is generally considered a:

Low-virulence opportunistic pathogen

Disease is therefore more likely when normal host defenses have been compromised.

Recovery from a clinical specimen should be interpreted according to:

Clinical syndrome + specimen source + host factors + repeated isolation

because environmental Gram-negative organisms may occasionally represent colonization or contamination.

Clinical Infections

Reported infections include:

• Peritonitis

• Bacteremia

• Skin and soft-tissue infection

• Respiratory tract infection

• Urinary tract infection

The severity ranges from localized disease to systemic infection.

Bacteremia

Sphingobacterium can cause:

Bloodstream infection

particularly in hospitalized or immunocompromised patients.

Potential sources may include:

• Intravascular devices

• Respiratory infection

• Urinary infection

• Soft-tissue infection

• Other healthcare-associated sources

High-Yield Bacteremia Pattern

Hospitalized patient

• ●

Fever or sepsis

• ●

Blood culture grows an unusual nonfermenting GNB

• ●

Sphingobacterium

→ Evaluate for true opportunistic bacteremia and a device-related source

Peritonitis

The organism can cause:

Peritonitis

This is particularly important when an invasive abdominal or dialysis-associated route provides access to the peritoneal cavity.

Diagnosis depends on compatible clinical findings and recovery of the organism from:

Peritoneal fluid

Respiratory Tract Infection

Sphingobacterium species have been associated with:

Respiratory tract infections

including lower respiratory disease in susceptible patients.

Potential manifestations include:

• Fever

• Cough

• Dyspnea

• Increased respiratory secretions

• Pulmonary infiltrates

Colonization vs. Respiratory Infection

Because unusual environmental Gram-negative organisms may colonize respiratory secretions, isolation from sputum alone does not always establish:

Pneumonia

Evidence supporting true infection includes:

Compatible symptoms

• ●

New pulmonary infiltrates

• ●

Inflammatory findings

• ●

Repeated or significant microbiologic isolation

Urinary Tract Infection

Sphingobacterium may cause:

Urinary tract infection

particularly in patients with:

• Urinary catheters

• Structural urinary abnormalities

• Repeated instrumentation

• Prolonged hospitalization

Clinical disease can range from:

Cystitis

to:

Complicated UTI or urosepsis

Skin and Soft-Tissue Infection

The organism can occasionally cause:

Skin and soft-tissue infections

particularly when normal skin barriers are disrupted by:

• Trauma

• Surgery

• Chronic wounds

• Medical procedures

Diagnosis

The principal diagnostic method is:

CULTURE

Appropriate specimens depend on the suspected site of infection.

These may include:

• Blood

• Urine

• Respiratory specimens

• Peritoneal fluid

• Wound or soft-tissue specimens

Laboratory Identification

Identification of uncommon nonfermenting Gram-negative bacilli can occasionally be challenging.

Modern laboratory techniques may assist in distinguishing Sphingobacterium from other environmental Gram-negative organisms.

For clinically significant isolates, accurate identification is important because:

Antimicrobial susceptibility patterns can be unpredictable.

Antimicrobial Susceptibility Testing

Treatment should ideally be based on:

Culture + antimicrobial susceptibility testing

because susceptibility may vary among species and individual isolates.

This is particularly important for:

Serious bloodstream or other invasive infections.

Treatment

The source lists:

Ampicillin

as the primary treatment.

However, because Sphingobacterium species can demonstrate variable antimicrobial susceptibility, a fixed empiric assumption of ampicillin susceptibility should be avoided.

Definitive therapy should be based on:

Individual susceptibility results.

Additional Treatment Options

The source lists the following potential agents:

• Trimethoprim–sulfamethoxazole

• Fluoroquinolones

• Third-generation cephalosporins

• Carbapenems

These should be considered:

Only when the clinical isolate is susceptible.

Resistance Considerations

Sphingobacterium species may possess resistance mechanisms affecting several antimicrobial classes.

Therefore:

Species identification alone does not reliably predict susceptibility.

This makes laboratory susceptibility testing particularly valuable when treating invasive disease.

High-Yield Treatment Principle

Sphingobacterium infection

→ Obtain appropriate culture

• ●

Perform susceptibility testing

• ●

Select an active antimicrobial

• ●

Control any infected device or anatomical source

Source Control

As with other opportunistic healthcare-associated Gram-negative infections, management should include evaluation for an:

Infected catheter, device, wound, or other persistent source

Examples include:

Bacteremia + central line

→ Evaluate the line as a possible source

UTI + urinary catheter

→ Remove or replace unnecessary catheter when appropriate

Peritonitis + indwelling device

→ Evaluate the device and associated source

Soft-tissue infection

→ Drain or debride infected collections when necessary

Sphingobacterium vs. Pseudomonas aeruginosa

Both may appear as:

Nonfermenting Gram-negative bacilli

and can cause healthcare-associated infections.

However:

Pseudomonas aeruginosa

→ Much more common human pathogen

→ Motile

→ Oxidase positive

→ Characteristic pigments may occur

→ Major cause of severe nosocomial infection

Sphingobacterium

→ Rare opportunistic pathogen

→ Generally nonmotile

→ Environmental organism

→ Characteristically contains sphingolipids

Sphingobacterium vs. Acinetobacter

Both can cause:

Healthcare-associated opportunistic infections

and may infect critically ill patients.

Acinetobacter

→ Gram-negative coccobacillus

→ Nonmotile

→ Important multidrug-resistant nosocomial pathogen

Sphingobacterium

→ Gram-negative bacillus

→ Rare human pathogen

→ Environmental organism with membrane sphingolipids

Prevention

There is no specific vaccine.

Prevention focuses on general healthcare infection-control practices, including:

• Hand hygiene

• Appropriate catheter care

• Limiting unnecessary invasive devices

• Proper respiratory equipment management

• Environmental cleaning

• Appropriate wound care

• Antimicrobial stewardship

High-Yield Clinical Pattern

Hospitalized/immunocompromised patient

• ●

Bacteremia, peritonitis, pneumonia, UTI, or soft-tissue infection

• ●

Rare aerobic nonfermenting Gram-negative bacillus

• ●

Environmental organism containing sphingolipids

→ Think SPHINGOBACTERIUM

Exam Essentials

Genus: Sphingobacterium

Important species: S. multivorum and S. spiritivorum

Organism: Aerobic Gram-negative bacillus

Metabolism: Generally nonfermenting

Motility: Generally nonmotile

Distinctive feature: Sphingolipids in the cell membrane

Distribution: Worldwide

Frequency: Rare human pathogen

Major epidemiologic setting: Nosocomial/healthcare-associated infection

Major infections: Bacteremia, peritonitis, respiratory infection, UTI, and skin/soft-tissue infection

Diagnosis: Culture

Important laboratory principle: Perform antimicrobial susceptibility testing

Source-listed treatment: Ampicillin

Additional source-listed agents: TMP-SMX, fluoroquinolones, third-generation cephalosporins, and carbapenems

Modern treatment principle: Use susceptibility-guided therapy because resistance patterns can vary

Management principle: Antimicrobial treatment plus source control when a device or localized focus is involved

Key clinical pearl: Sphingobacterium species are rare environmental, nonfermenting Gram-negative bacilli characterized by sphingolipids in their cell membranes. They primarily behave as opportunistic healthcare-associated pathogens, causing bacteremia, peritonitis, respiratory infection, UTI, and skin or soft-tissue disease. Because antimicrobial susceptibility can be variable, a clinically significant isolate should be treated according to culture and susceptibility results rather than assuming that a particular antibiotic will be active.

Infectious Disease and Microbiology – Smallpox Virus (Variola Virus)

Overview

Smallpox is a severe, highly contagious systemic viral disease caused by variola virus, a member of the genus Orthopoxvirus within the family Poxviridae.

Variola virus is a large, enveloped double-stranded DNA virus. Smallpox was successfully eradicated through a global vaccination campaign, with the last naturally occurring case reported in Somalia in 1977. The World Health Organization declared smallpox eradicated in 1980.

Because routine transmission no longer occurs, any suspected case of smallpox today would constitute an extraordinary public-health emergency requiring immediate involvement of public-health authorities.

Classification

Family: Poxviridae

Genus: Orthopoxvirus

Virus: Variola virus

Disease: Smallpox (variola)

Other members of the Orthopoxvirus group include viruses responsible for diseases such as mpox and cowpox.

Microbiologic Characteristics

Variola virus is:

• A DNA virus

• Double-stranded DNA (dsDNA)

• Enveloped

• Large and structurally complex

• A member of the Poxviridae family

• Characterized by replication predominantly in the cytoplasm

The cytoplasmic replication of poxviruses is a particularly important microbiologic feature.

High-Yield Microbiology Pattern

Large enveloped dsDNA virus

• ●

Complex structure

• ●

Replicates in cytoplasm

• ●

Orthopoxvirus

→ Think POXVIRIDAE

Incubation Period

The source gives an incubation period of approximately:

12 days

More broadly, smallpox classically develops after an incubation period of roughly:

1–2 weeks

During the incubation period, patients generally do not have the characteristic rash.

Epidemiology

Smallpox once occurred worldwide and caused enormous morbidity and mortality.

Through:

Mass vaccination + surveillance + case identification + containment

human transmission was eliminated.

Eradication

The last naturally occurring case of smallpox was reported in:

Somalia — October 1977

Global eradication was subsequently certified by the:

World Health Organization in 1980

Smallpox remains one of the landmark achievements of infectious-disease prevention.

High-Yield Historical Pattern

Last naturally occurring case

→ Somalia, 1977

Global eradication certified

→ 1980

Current Status

Smallpox does not circulate naturally in the human population.

Variola virus has historically been retained under:

Strictly controlled high-security laboratory conditions

for authorized research purposes.

Consequently, a suspected contemporary case would require:

Immediate public-health and specialized laboratory response.

Transmission

Historically, smallpox was transmitted primarily through:

Close person-to-person exposure to infectious respiratory secretions or lesion material

Transmission could also occur through contaminated materials associated with infected patients.

Humans were the natural reservoir responsible for maintaining transmission.

The absence of a nonhuman reservoir was an important factor that made:

Global eradication possible.

Clinical Infection

Variola virus causes:

SMALLPOX

The disease classically progresses through:

Incubation

↓

Acute systemic prodrome

↓

Characteristic rash

↓

Papules

↓

Vesicles

↓

Pustules

↓

Crusting/scabbing

↓

Healing

Prodromal Illness

Before the characteristic rash appears, patients classically develop a significant systemic illness that may include:

• High fever

• Severe malaise

• Headache

• Backache

• Marked constitutional symptoms

The patient is generally:

Systemically ill before or around the appearance of the rash.

Smallpox Rash

The characteristic eruption begins with:

Macules

that progress through:

Papules → vesicles → pustules → crusts/scabs

The lesions are typically:

Deep-seated, firm, and well circumscribed

rather than superficial fragile vesicles.

Centrifugal Distribution

A classic feature is the:

CENTRIFUGAL DISTRIBUTION

of the rash.

The lesion burden is particularly prominent on:

Face + distal extremities

rather than being concentrated primarily on the trunk.

Palms and Soles

Smallpox lesions may involve the:

Palms and soles

This is an important diagnostic clue when evaluating a generalized vesiculopustular eruption.

Synchronous Lesions

One of the most important classic characteristics is that lesions in a given body area tend to be at:

THE SAME STAGE OF DEVELOPMENT

For example, an affected region may predominantly contain:

Vesicles

or:

Pustules

rather than many different lesion stages simultaneously.

High-Yield Rash Pattern

Severe febrile prodrome

• ●

Deep vesiculopustular eruption

• ●

Face and distal extremities > trunk

• ●

Palms/soles may be involved

• ●

Lesions in the same area at approximately the same developmental stage

→ Think SMALLPOX

Smallpox vs. Chickenpox

This is a classic examination distinction.

Smallpox

Distribution: Centrifugal

Face/extremities: Prominent

Trunk: Less concentrated

Palms/soles: May be involved

Lesions: Deep and firm

Development: Lesions in a region are generally at a similar stage

Prodrome: Usually significant systemic illness

Chickenpox (Varicella)

Distribution: Predominantly centripetal

Trunk: More heavily involved

Extremities: Less prominent

Lesions: More superficial

Development: Multiple stages simultaneously are characteristic

Prodrome: Generally milder, particularly in children

Classic Exam Comparison

Same-stage lesions + centrifugal distribution

→ SMALLPOX

Different-stage lesions + centripetal distribution

→ CHICKENPOX

Smallpox vs. Mpox

Both are caused by:

Orthopoxviruses

and both can produce:

Vesiculopustular lesions

However, they are distinct diseases.

Smallpox is caused by:

Variola virus

whereas mpox is caused by:

Monkeypox virus

Smallpox has been eradicated, while mpox continues to occur in humans.

Diagnosis

Historically, diagnosis involved:

• Clinical features

• Viral culture

• Electron microscopy

• Serologic testing

However, in a contemporary suspected case, routine diagnostic handling would be inappropriate because of the enormous public-health and biosafety implications.

Clinical Recognition

The characteristic syndrome includes:

Severe febrile illness

followed by:

Deep-seated vesiculopustular rash

with:

Centrifugal distribution and synchronous lesion development

Electron Microscopy

Electron microscopy can demonstrate particles with morphology consistent with:

Poxviruses

However, morphology alone does not necessarily distinguish all individual orthopoxviruses.

Modern Laboratory Confirmation

Modern confirmation would rely on specialized:

Molecular testing, particularly PCR

performed through appropriate public-health and specialized laboratory systems.

Suspected variola specimens should not be handled as ordinary routine clinical specimens.

Public-Health Response

A suspected case requires urgent:

Isolation

• ●

Public-health notification

• ●

Specialized diagnostic coordination

• ●

Contact identification and management

Because naturally occurring smallpox has been eradicated, even a single confirmed case would be an:

International public-health emergency.

Treatment

The supplied source lists:

Cidofovir

as a possible treatment.

However, contemporary preparedness includes antivirals developed or maintained specifically for orthopoxvirus emergencies.

Management of an actual suspected or confirmed smallpox case would occur under:

Specialist and public-health authority guidance.

Tecovirimat

Tecovirimat is an antiviral with activity against orthopoxviruses and is an important component of modern smallpox preparedness.

Other antiviral strategies may be considered by public-health specialists depending on the circumstances.

Cidofovir

Cidofovir has activity against poxviruses and historically has been discussed as a possible treatment.

Its clinical use is limited by factors including:

Potential nephrotoxicity

and it would not be used casually for a suspected smallpox case.

Vaccination

Vaccination was the central intervention responsible for:

Global eradication of smallpox

Traditional smallpox vaccines use:

Vaccinia virus

rather than variola virus itself.

Post-Exposure Vaccination

Vaccination can have an important role after recognized exposure because administration sufficiently early after exposure may:

Prevent disease or reduce disease severity.

This principle historically formed part of:

Ring vaccination

strategies.

Ring Vaccination

A major eradication strategy involved identifying:

A case

↓

Finding:

Close contacts

↓

Vaccinating appropriate contacts and surrounding at-risk individuals

↓

Interrupting transmission

This strategy helped eliminate remaining chains of smallpox transmission.

Routine Vaccination

Routine smallpox vaccination of the general population was discontinued after eradication because:

Natural smallpox exposure no longer occurs

and smallpox vaccines can produce significant adverse effects.

Vaccination is therefore reserved primarily for:

Specific occupational or emergency-preparedness indications.

Prevention

The cornerstone of historical prevention was:

SMALLPOX VACCINATION

Contemporary prevention and preparedness emphasize:

• Appropriate vaccination of selected at-risk personnel

• Rapid recognition of suspected disease

• Immediate patient isolation

• Public-health notification

• Contact tracing

• Appropriate post-exposure vaccination strategies

• Specialized infection-control measures

Why Smallpox Could Be Eradicated

Several biological features favored eradication:

Humans were the major reservoir

• ●

Characteristic clinical disease facilitated recognition

• ●

Effective vaccine available

• ●

No persistent major animal reservoir

• ●

Coordinated worldwide surveillance and vaccination

→ GLOBAL ERADICATION

High-Yield Clinical Pattern

Severe fever and systemic prodrome

• ●

Deep papules → vesicles → pustules

• ●

Face and distal extremities heavily involved

• ●

Palms and soles may be affected

• ●

Lesions in the same region at the same developmental stage

→ Think SMALLPOX (VARIOLA)

Exam Essentials

Virus: Variola virus

Genus: Orthopoxvirus

Family: Poxviridae

Genome: Double-stranded DNA

Envelope: Present

Replication: Primarily cytoplasmic

Incubation: Approximately 12 days in the source

Disease: Smallpox

Rash progression: Macule → papule → vesicle → pustule → crust

Distribution: Centrifugal

Major lesion burden: Face and distal extremities

Palms/soles: May be involved

Lesion stages: Generally synchronous within a body region

Last naturally occurring case: Somalia, 1977

Eradication certified: 1980

Historical diagnosis: Clinical features, culture, EM, serology

Modern confirmation: Specialized PCR-based testing

Source treatment: Possible cidofovir and vaccination

Modern preparedness antiviral: Tecovirimat is important

Vaccine virus: Vaccinia virus

Major prevention achievement: Global eradication through vaccination and surveillance

Key clinical pearl: Smallpox is an eradicated orthopoxvirus infection caused by variola virus. Its classic examination pattern is a severe febrile prodrome followed by a deep, centrifugal vesiculopustular eruption concentrated on the face and distal extremities, with lesions in a given region developing synchronously—unlike the different-stage, trunk-predominant lesions of chickenpox. Because naturally occurring smallpox no longer exists, any suspected case today would require immediate isolation and urgent public-health coordination rather than routine clinical laboratory handling.

Infectious Disease and Microbiology – Serratia Species

Overview

Serratia species are Gram-negative bacilli belonging to the order Enterobacterales. Although several species can occasionally cause human disease, Serratia marcescens is by far the most clinically important.

Serratia is particularly associated with healthcare-associated infections, especially in hospitalized patients exposed to invasive procedures, urinary or vascular catheters, mechanical ventilation, or prolonged antimicrobial therapy. Important syndromes include bacteremia, urinary tract infection, pneumonia, intra-abdominal infection, wound infection, and device-associated infection.

Classification

Genus: Serratia

Important species include:

• Serratia ficaria

• Serratia fonticola

• Serratia grimesii

• Serratia liquefaciens

• Serratia marcescens — most clinically relevant species

• Serratia odorifera

• Serratia plymuthica

• Serratia rubidaea

• Other Serratia species

Microbiologic Characteristics

Serratia species are:

• Gram-negative bacilli

• Members of Enterobacterales

• Facultatively anaerobic, although the source describes them as aerobic

• Generally oxidase-negative

• Usually motile

• Capable of surviving in moist environmental and healthcare settings

These properties contribute to their ability to colonize:

Hospital environments + medical equipment + fluids

Serratia marcescens

Serratia marcescens is the major human pathogen within the genus.

It is an important:

Opportunistic nosocomial Gram-negative bacillus

and can produce outbreaks in:

• Intensive care units

• Neonatal units

• Surgical wards

• Other healthcare environments

Red Pigmentation

A classic microbiologic feature of some S. marcescens strains is production of the red pigment:

PRODIGIOSIN

This can produce:

Pink to red colonies

under appropriate growth conditions.

However, an important practical point is that:

Not all clinical isolates produce visible red pigment.

Therefore, absence of red pigmentation does not exclude S. marcescens.

High-Yield Microbiology Pattern

Gram-negative bacillus

• ●

Healthcare-associated infection

• ●

Possible red pigment (prodigiosin)

→ Think Serratia marcescens

Epidemiology

Serratia species have a:

Worldwide distribution

The organism is found in environmental reservoirs, particularly:

Water and moist environments

Its ability to survive under relatively nutrient-poor conditions contributes to its importance in healthcare-associated transmission.

Nosocomial Infection

The source emphasizes that Serratia is commonly associated with:

NOSOCOMIAL INFECTION

Major risk factors include:

• Hospitalization

• Intensive care exposure

• Invasive procedures

• Central venous catheters

• Urinary catheters

• Mechanical ventilation

• Surgery

• Broad-spectrum antibiotic exposure

• Significant underlying illness

High-Yield Nosocomial Pattern

Hospitalized patient

• ●

Invasive device/procedure

• ●

Gram-negative bacteremia, UTI, or pneumonia

→ Consider Serratia marcescens

Intravenous Drug Use

Another important risk factor described in the source is:

Intravenous drug use

This is particularly relevant because bloodstream inoculation can produce:

Bacteremia

and potentially:

Infective endocarditis

Healthcare Reservoirs

Serratia can persist in moist healthcare environments and has historically been associated with contamination of:

• Solutions

• Medical equipment

• Respiratory equipment

• Sinks and water-associated environments

This ability contributes to:

Healthcare-associated outbreaks

Clinical Infections

Serratia can cause infection at multiple anatomical sites.

Major syndromes include:

Bacteremia

Urinary tract infection

Respiratory tract infection

Intra-abdominal infection

Other invasive infections may also occur.

Bacteremia

Serratia can cause:

Bloodstream infection

particularly in hospitalized patients with:

Central venous catheters or other invasive devices

Potential sources include:

• Urinary tract

• Respiratory tract

• Intra-abdominal infection

• Vascular catheter

• Wound or surgical infection

High-Yield Bacteremia Pattern

Hospitalized patient

• ●

Central venous catheter

• ●

Gram-negative bacteremia

• ●

S. marcescens cultured

→ Consider catheter-associated Serratia bloodstream infection

Urinary Tract Infection

Serratia is an important cause of:

Healthcare-associated UTI

particularly in patients with:

Indwelling urinary catheters

Clinical manifestations range from:

Catheter-associated bacteriuria

to:

Cystitis → pyelonephritis → urosepsis

Respiratory Tract Infection

Serratia may cause:

Hospital-acquired pneumonia

particularly in:

• Mechanically ventilated patients

• Critically ill patients

• Patients with prolonged hospitalization

• Patients with significant underlying disease

Ventilator-associated infection is an important healthcare-associated presentation.

Intra-Abdominal Infection

Serratia can also participate in:

Intra-abdominal infections

particularly following:

• Surgery

• Gastrointestinal disruption

• Invasive procedures

• Severe underlying illness

Such infections may be:

Polymicrobial

and require both antimicrobial therapy and appropriate source control.

Wound and Surgical-Site Infection

Serratia may infect:

Surgical wounds

or other disrupted tissue.

The organism should be considered particularly when infection develops in a healthcare setting or after exposure to contaminated medical material.

Endocarditis

Although less common than bacteremia or UTI, Serratia can cause:

Infective endocarditis

A classic epidemiologic association is:

Injection drug use

although healthcare-associated and device-related cases may also occur.

High-Yield Endocarditis Pattern

Injection drug use

• ●

Persistent Gram-negative bacteremia

• ●

Endocarditis

→ Consider Serratia marcescens

Other Invasive Infections

Less commonly, Serratia species can cause:

• Osteomyelitis

• Septic arthritis

• Meningitis

• Endophthalmitis

• Skin and soft-tissue infection

These manifestations generally occur in patients with relevant:

Healthcare exposure, trauma, devices, or impaired host defenses.

Diagnosis

The primary diagnostic method is:

CULTURE

Appropriate specimens depend on the clinical syndrome and may include:

• Blood

• Urine

• Respiratory specimens

• Wound material

• Intra-abdominal fluid

• CSF

• Other normally sterile specimens

Antimicrobial Susceptibility Testing

A particularly important component of diagnosis is:

ANTIMICROBIAL SUSCEPTIBILITY TESTING

Treatment should be selected according to:

Organism identification + infection site + severity + susceptibility results

because Serratia can possess important antimicrobial resistance mechanisms.

Antimicrobial Resistance

Serratia species possess clinically important resistance mechanisms.

S. marcescens has intrinsic resistance to several antimicrobial agents and may acquire additional resistance mechanisms.

Of particular concern are:

• β-lactamase-mediated resistance

• ESBL production in some isolates

• Carbapenemase production in some strains

• Multidrug-resistant healthcare-associated isolates

Therefore:

Susceptibility testing is essential.

AmpC β-Lactamase

S. marcescens possesses a chromosomal:

AmpC β-lactamase

This contributes to resistance to several β-lactam antibiotics.

The clinical importance of AmpC behavior varies among Enterobacterales, so definitive treatment should be guided by:

Current susceptibility results and the severity/site of infection.

Important Intrinsic Resistance

A classic high-yield feature is that Serratia is intrinsically resistant to agents such as:

Ampicillin

and

Early-generation cephalosporins

Therefore, these should not be assumed to provide reliable treatment.

High-Yield Resistance Pattern

Serratia marcescens

→ Healthcare-associated pathogen

→ Chromosomal AmpC β-lactamase

→ Possible additional acquired resistance

→ Always review susceptibility results

Treatment

The source appropriately emphasizes that treatment should be:

BASED ON SUSCEPTIBILITY DATA

There is no single antibiotic that should automatically be used for every Serratia infection.

Choice depends on:

Susceptibility + infection site + disease severity + resistance mechanism + patient factors

Fluoroquinolones

The source lists:

Ciprofloxacin

and other fluoroquinolones as potential treatments when the isolate is susceptible.

These agents may be useful for selected infections, particularly when:

Susceptibility is confirmed.

Cephalosporins

The source lists:

Third-generation cephalosporins

as potential treatment options.

Because resistance mechanisms may complicate β-lactam therapy, the specific agent should be chosen according to:

Susceptibility testing and clinical context.

Carbapenems

Potential agents include:

Meropenem

and

Imipenem

Carbapenems may be particularly relevant for serious infections caused by organisms with certain resistant β-lactamase phenotypes, provided the isolate remains:

Carbapenem susceptible

Other Potential Agents

Depending on susceptibility, the source also lists:

• Aztreonam

• Ureidopenicillins

• Aminoglycosides

• Ofloxacin

• Trimethoprim–sulfamethoxazole

The choice should not be made solely on the basis of species identification.

Source Control

Treatment of invasive Serratia infection frequently requires attention to:

SOURCE CONTROL

Examples include:

Central-line infection

→ Remove or replace implicated catheter when appropriate

Catheter-associated UTI

→ Remove or replace unnecessary urinary catheter

Intra-abdominal abscess

→ Drain infected collection

Obstruction

→ Correct anatomical obstruction

Infected prosthetic material

→ Evaluate need for device removal

High-Yield Management Pattern

Serratia infection

→ Obtain cultures

• ●

Perform susceptibility testing

• ●

Choose active antimicrobial therapy

• ●

Control/remove the infectious source

Serratia vs. Pseudomonas aeruginosa

Both are important:

Healthcare-associated Gram-negative pathogens

However:

Serratia marcescens

→ Enterobacterales

→ Oxidase negative

→ May produce red prodigiosin pigment

Pseudomonas aeruginosa

→ Nonfermenting Gram-negative bacillus

→ Oxidase positive

→ Characteristic blue-green pigments may occur

Serratia vs. Enterobacter

Both can cause:

Nosocomial UTI, pneumonia, and bacteremia

and both may have:

Chromosomal AmpC β-lactamases

However, the classic distinguishing clue for Serratia marcescens is:

Red prodigiosin pigmentation

although this feature is not present in every clinical isolate.

Serratia vs. Klebsiella

Serratia

→ Usually motile

→ Possible red pigmentation

→ Healthcare-associated opportunistic pathogen

Klebsiella

→ Nonmotile

→ Prominent polysaccharide capsule

→ Classically produces very mucoid colonies

Both may acquire:

ESBLs and carbapenemases

and cause multidrug-resistant healthcare-associated infections.

Prevention

Prevention focuses primarily on:

Healthcare infection-control practices

including:

• Hand hygiene

• Appropriate central-line care

• Appropriate urinary catheter care

• Proper respiratory equipment management

• Environmental cleaning

• Avoidance of unnecessary invasive devices

• Appropriate antimicrobial stewardship

Healthcare-associated clusters should raise concern for:

A common environmental or equipment-related source.

High-Yield Clinical Pattern

Hospitalized patient

• ●

Invasive catheter or procedure

• ●

Bacteremia, UTI, or pneumonia

• ●

Gram-negative bacillus

• ●

Possible red pigment

→ Think SERRATIA MARCESCENS

Exam Essentials

Genus: Serratia

Most clinically important species: Serratia marcescens

Organism: Gram-negative bacillus

Order: Enterobacterales

Metabolism: Facultatively anaerobic

Oxidase: Negative

Motility: Usually motile

Classic pigment: Prodigiosin → red/pink pigmentation

Important caveat: Not all clinical isolates are visibly pigmented

Distribution: Worldwide

Major epidemiologic setting: Healthcare-associated infection

Risk factors: Hospitalization, invasive procedures/devices, critical illness, and injection drug use

Major infections: Bacteremia, UTI, pneumonia, and intra-abdominal infection

Additional infection: Endocarditis, particularly associated historically with injection drug use

Diagnosis: Culture

Resistance issue: Chromosomal AmpC β-lactamase plus potential acquired resistance mechanisms

Treatment principle: Susceptibility-guided antimicrobial therapy

Source-listed options: Ciprofloxacin/other fluoroquinolones, third-generation cephalosporins, carbapenems, aztreonam, ureidopenicillins, aminoglycosides, ofloxacin, and TMP-SMX when active

Management principle: Antibiotic therapy + appropriate source control

Key clinical pearl: Serratia marcescens is the most clinically important Serratia species and is primarily a healthcare-associated Gram-negative pathogen causing catheter-associated bacteremia, UTI, pneumonia, and other invasive infections. Its classic microbiology clue is production of the red pigment prodigiosin, although many clinical isolates are nonpigmented. Because Serratia possesses intrinsic and acquired antimicrobial resistance mechanisms, definitive therapy should be guided by susceptibility testing rather than by a fixed antibiotic regimen.

Infectious Disease and Microbiology – Scopulariopsis Species

Overview

Scopulariopsis species are filamentous environmental fungi (molds) with a worldwide distribution. They are most commonly associated with onychomycosis, but they can also produce locally invasive or disseminated infections, particularly in immunocompromised patients.

Important manifestations include otitis externa, keratitis, pulmonary infection, cutaneous disease, endocarditis, and disseminated infection. A major clinical challenge is that Scopulariopsis species often demonstrate poor or variable susceptibility to multiple antifungal agents, making invasive disease difficult to treat.

Classification

Genus: Scopulariopsis

Important species include:

• Scopulariopsis brevicaulis — one of the most clinically important species

• Scopulariopsis brumptii

• Other Scopulariopsis species

Microbiologic Characteristics

Scopulariopsis species are:

• Filamentous fungi (molds)

• Environmental organisms

• Generally characterized by septate hyphae

• Capable of producing characteristic conidia in culture

They belong to the group of molds capable of producing:

Hyalohyphomycosis

when hyaline hyphae invade human tissue.

High-Yield Microbiology Pattern

Environmental filamentous mold

• ●

Onychomycosis

• ●

Opportunistic invasive infection

• ●

Poor antifungal susceptibility

→ Think Scopulariopsis

Epidemiology

Scopulariopsis species have a:

Worldwide distribution

They are widespread environmental saprophytes and may be encountered in:

• Soil

• Decaying organic material

• Plant material

• Indoor environments

Human disease remains relatively uncommon.

Incubation Period

The incubation period is:

Unknown

Because infections may develop after environmental inoculation, local colonization, or opportunistic invasion, there is no characteristic incubation period.

Spectrum of Disease

Clinical infection can be divided broadly into:

Superficial disease

↓

Locally invasive disease

↓

Disseminated invasive disease

The patient’s:

Immune status

is an important determinant of severity.

Onychomycosis

The most familiar infection associated with Scopulariopsis is:

ONYCHOMYCOSIS

particularly involving the:

Toenails

S. brevicaulis is an important nondermatophyte mold associated with nail infection.

Clinical Features of Onychomycosis

Affected nails may become:

• Thickened

• Discolored

• Brittle

• Irregular

• Dystrophic

• Partially separated from the nail bed

Because environmental molds can contaminate nail specimens, laboratory isolation should be interpreted carefully.

High-Yield Nail Pattern

Chronic dystrophic nail

• ●

Nondermatophyte environmental mold

• ●

Scopulariopsis brevicaulis

→ Scopulariopsis onychomycosis

Otitis Externa

Scopulariopsis may cause:

Locally invasive otitis externa

particularly in susceptible patients.

Symptoms may include:

• Ear pain

• Pruritus

• Otorrhea

• Inflammation of the external auditory canal

Severe infection can extend into surrounding tissues.

Keratitis

Another important localized infection is:

FUNGAL KERATITIS

This may follow:

• Ocular trauma

• Environmental exposure

• Corneal disruption

Clinical manifestations may include:

• Eye pain

• Redness

• Photophobia

• Reduced vision

• Corneal infiltrates or ulceration

High-Yield Ocular Pattern

Corneal trauma

• ●

Progressive keratitis

• ●

Filamentous environmental mold

→ Consider Scopulariopsis

Cutaneous Infection

Cutaneous lesions have been reported particularly in patients with:

Advanced immunosuppression

including patients with advanced HIV infection.

Disease may remain localized or represent evidence of:

Disseminated fungal infection

depending on the clinical setting.

Pulmonary Infection

Scopulariopsis species may cause:

Pulmonary infection

particularly in patients with impaired host defenses.

Manifestations may include:

• Fever

• Cough

• Dyspnea

• Pulmonary infiltrates or nodules

• Cavitary abnormalities in some cases

Isolation from respiratory specimens must be interpreted carefully because environmental molds may sometimes represent:

Colonization or contamination

rather than invasive disease.

Endocarditis

Scopulariopsis is a:

Rare cause of fungal endocarditis

This represents a severe invasive manifestation.

Prosthetic cardiac material, previous cardiac surgery, or major immunosuppression may increase concern for true infection.

Disseminated Infection

Severe disseminated disease occurs primarily in:

Immunocompromised hosts

and is particularly concerning in patients with:

Neutropenia

Neutropenic Patients

In profoundly neutropenic patients, the organism can invade tissues and spread hematogenously.

Potential sites of dissemination include:

• Skin

• Lungs

• Heart

• CNS

• Other internal organs

Such infection can be extremely difficult to treat.

High-Yield Invasive Pattern

Neutropenic patient

• ●

Persistent fever

• ●

Pulmonary or disseminated mold infection

• ●

Poor response to conventional antifungal therapy

→ Consider Scopulariopsis

Diagnosis

Although not explicitly listed in the supplied diagnosis section, clinically suspected infection is generally established through:

Culture

and, for invasive disease:

Histopathologic demonstration of tissue invasion

Culture

Culture allows:

• Identification of the mold

• Species-level characterization

• Antifungal susceptibility testing when appropriate

Repeated isolation can be particularly helpful when distinguishing:

True nail infection

from:

Environmental contamination

Histopathology

In invasive disease, tissue examination may demonstrate:

Septate hyaline hyphae

within affected tissues.

However, histologic appearance may resemble other hyaline molds, so:

Culture or molecular identification

may be needed for definitive species identification.

Contamination vs. True Infection

Because Scopulariopsis is common in the environment, a positive culture does not automatically establish disease.

Clinical significance is increased by:

Repeated isolation

• ●

Compatible clinical syndrome

• ●

Immunocompromised host

• ●

Isolation from a normally sterile site

or

Histopathologic evidence of tissue invasion

Scopulariopsis vs. Dermatophytes

Both can cause:

Onychomycosis

However:

Dermatophytes

→ Most common causes of onychomycosis

Scopulariopsis

→ Nondermatophyte mold

→ Less common cause

→ Repeated culture may be useful to establish pathogenic significance

Scopulariopsis vs. Aspergillus

Both are:

Septate filamentous molds

and both can produce invasive infection in immunocompromised hosts.

Aspergillus

→ Much more common cause of invasive mold infection

→ Classic acute-angle branching septate hyphae

Scopulariopsis

→ Particularly associated with onychomycosis

→ Rare invasive disease

→ Frequently demonstrates broad antifungal resistance

Scopulariopsis vs. Lomentospora prolificans

Both can cause:

Severe resistant mold infections

in immunocompromised hosts.

Scopulariopsis

→ Classic superficial association with onychomycosis

Lomentospora prolificans

→ Particularly associated with marked multidrug resistance, bone/joint infection, and disseminated disease

Precise identification is important because susceptibility patterns can differ.

Treatment of Onychomycosis

The source recommends:

Chemical nail removal with 40% urea

for patients with onychomycosis.

This approach softens and facilitates removal of diseased nail tissue.

Surgical Nail Removal

The source also lists:

Surgical removal of the affected nail or nails

as a treatment option.

Mechanical or surgical removal can reduce the burden of infected tissue.

High-Yield Nail Treatment Pattern

Scopulariopsis onychomycosis

→ Chemical nail removal with 40% urea

or

→ Surgical removal of affected nail

Antifungal Therapy

The source emphasizes that there are:

Limited data regarding the efficacy of antifungal agents

against Scopulariopsis.

This remains clinically important because susceptibility can be:

Variable and often poor

Antifungal Resistance

Scopulariopsis species may demonstrate reduced susceptibility or resistance to multiple antifungal classes.

Therefore, invasive infection should ideally be managed using:

Accurate species identification

• ●

Antifungal susceptibility testing

• ●

Clinical response

• ●

Specialist guidance

Amphotericin B

The source lists:

Intravenous amphotericin B

for:

Invasive infections

However, Scopulariopsis species may demonstrate limited susceptibility to amphotericin B, so treatment response can be unpredictable.

Thus, amphotericin B should not be assumed to have uniformly reliable activity against all isolates.

Management of Invasive Disease

Because invasive Scopulariopsis infection can be difficult to eradicate, management may require:

Systemic antifungal therapy

• ●

Susceptibility testing

• ●

Surgical removal/debridement of infected tissue when feasible

• ●

Removal of infected prosthetic material when appropriate

• ●

Recovery of host immune function

Role of Immune Recovery

In patients with neutropenia or other severe immunosuppression:

Restoration of host immunity

can be crucial for successful treatment.

Persistent profound neutropenia is associated with difficulty controlling invasive mold infection.

High-Yield Management Principle

Invasive Scopulariopsis infection

→ Species identification

• ●

Susceptibility-guided antifungal therapy

• ●

Surgical source control when possible

• ●

Reverse immunosuppression/neutropenia when feasible

Prevention

There is no specific vaccine.

General preventive principles include:

• Appropriate nail and foot hygiene

• Avoiding unnecessary nail trauma

• Prompt treatment of traumatic ocular injuries

• Appropriate infection prevention in severely immunocompromised patients

• Careful evaluation of unusual mold isolates in neutropenic patients

High-Yield Clinical Pattern

Chronic onychomycosis

• ●

Nondermatophyte environmental mold

→ Think Scopulariopsis brevicaulis

OR

Neutropenic/immunocompromised patient

• ●

Invasive pulmonary or disseminated mold infection

• ●

Broad antifungal resistance

→ Consider SCOPULARIOPSIS

Exam Essentials

Genus: Scopulariopsis

Important species: S. brevicaulis and S. brumptii

Organism: Filamentous fungus (mold)

Distribution: Worldwide

Incubation: Unknown

Classic superficial infection: Onychomycosis

Locally invasive disease: Otitis externa and keratitis

Pulmonary disease: Possible, especially in susceptible hosts

Cutaneous disease: Reported in advanced immunosuppression

Endocarditis: Rare

Disseminated infection: Particularly important in neutropenic patients

Diagnosis: Culture; histopathology for evidence of invasive disease

Major diagnostic issue: Distinguish environmental contamination/colonization from true infection

Source treatment for onychomycosis: 40% urea chemical nail removal

Additional local treatment: Surgical nail removal

Source treatment for invasive disease: IV amphotericin B

Important modern treatment issue: Antifungal susceptibility is often poor or variable, and amphotericin B may not provide reliable activity

Management of invasive disease: Susceptibility-guided therapy + source control + restoration of immune function when possible

Key clinical pearl: Scopulariopsis, particularly S. brevicaulis, is a nondermatophyte environmental mold classically associated with onychomycosis but capable of causing keratitis, otitis, pulmonary disease, endocarditis, and life-threatening disseminated infection in neutropenic or otherwise immunocompromised patients. Invasive disease is especially challenging because susceptibility to conventional antifungal agents—including amphotericin B—may be poor, making accurate identification, susceptibility testing, source control, and immune recovery important components of management.

Infectious Disease and Microbiology – Sarcocystis Species

Overview

Sarcocystis species are intracellular protozoan parasites belonging to the coccidian group. Human sarcocystosis occurs in two major forms:

Intestinal sarcocystosis and muscular sarcocystosis.

The intestinal form is usually mild and follows ingestion of raw or undercooked meat containing sarcocysts, whereas muscular sarcocystosis occurs when humans act as accidental intermediate hosts and may produce myalgia, muscle swelling, fever, and eosinophilia.

Classification

Genus: Sarcocystis

Important species associated with human intestinal infection include:

• Sarcocystis bovihominis — associated with beef

• Sarcocystis suihominis — associated with pork

The parasites are related to other intestinal coccidian protozoa.

Microbiologic Characteristics

Sarcocystis species are:

• Protozoan parasites

• Intracellular

• Coccidian organisms

• Characterized by formation of sarcocysts within muscle tissue during part of their life cycle

The source describes their characteristics as similar to those of Cystoisospora belli, historically called Isospora belli.

High-Yield Microbiology Pattern

Coccidian protozoan

• ●

Sarcocysts in muscle

• ●

Raw beef or pork exposure

• ●

Mild gastrointestinal illness

→ Think Sarcocystis

Life Cycle

Sarcocystis generally requires:

Two hosts

for completion of its life cycle.

These consist of:

Definitive host

and

Intermediate host

Humans as Definitive Hosts

In intestinal sarcocystosis, humans become:

Definitive hosts

after consuming meat containing mature:

Sarcocysts

Beef-Associated Infection

Sarcocystis bovihominis

is associated with:

Cattle

Humans acquire intestinal infection by consuming:

Raw or inadequately cooked beef containing sarcocysts

Pork-Associated Infection

Sarcocystis suihominis

is associated with:

Pigs

Humans acquire infection through consumption of:

Raw or inadequately cooked pork containing sarcocysts

High-Yield Food Association

S. bovihominis

→ BOVINE

→ BEEF

S. suihominis

→ SWINE

→ PORK

Intestinal Life Cycle

Raw/undercooked infected beef or pork

↓

Ingestion of sarcocysts

↓

Parasites released in intestine

↓

Sexual reproduction in intestinal epithelium

↓

Sporocysts/oocysts passed in feces

↓

Intestinal sarcocystosis

Humans as Intermediate Hosts

Humans can also become accidental:

Intermediate hosts

after ingesting infective sporocysts from contaminated environmental material.

Parasites then disseminate and eventually form:

Sarcocysts within skeletal muscle

resulting in:

Muscular sarcocystosis

Two Forms of Human Disease

The distinction between the two forms is important:

Intestinal Sarcocystosis

Human = definitive host

Raw beef/pork → intestine

Muscular Sarcocystosis

Human = accidental intermediate host

Sporocysts → systemic migration → skeletal muscle sarcocysts

High-Yield Life-Cycle Pattern

Raw meat

→ Human becomes definitive host

→ Intestinal disease

Environmental sporocysts

→ Human becomes intermediate host

→ Muscular disease

Incubation Period

The source describes the incubation period as:

Unclear

The timing depends partly on whether the infection manifests as intestinal or muscular disease.

Epidemiology

Sarcocystis species have a:

Worldwide distribution

Human infection has been documented in numerous geographic regions.

The source notes that many reported cases have occurred in:

Southeast Asia

Intestinal Sarcocystosis

Intestinal disease is generally:

Mild and self-limited

Some infected individuals remain:

Asymptomatic

When symptoms occur, they may include:

• Nausea

• Abdominal discomfort

• Diarrhea

• Other mild gastrointestinal symptoms

High-Yield Intestinal Pattern

Raw or undercooked beef/pork

• ●

Mild gastrointestinal symptoms

• ●

Sporocysts detected in stool

→ Intestinal sarcocystosis

Muscular Sarcocystosis

Muscular sarcocystosis is also frequently:

Asymptomatic

In fact, sarcocysts may be discovered incidentally during:

Muscle biopsy

or histopathologic examination performed for another reason.

Symptomatic Muscular Disease

When muscular disease becomes clinically apparent, manifestations may include:

• Myalgia

• Muscle tenderness

• Muscle swelling

• Weakness

• Fever in some patients

Inflammation surrounding infected muscle tissue may produce a clinical picture of:

Myositis

Eosinophilia

Because muscular sarcocystosis represents a tissue-invasive parasitic infection, patients may demonstrate:

Peripheral eosinophilia

This can provide an additional diagnostic clue when combined with:

Myalgia + epidemiologic exposure

High-Yield Muscular Pattern

Southeast Asian exposure

• ●

Myalgia

• ●

Muscle swelling

• ●

Eosinophilia

• ●

Sarcocysts on muscle biopsy

→ Think MUSCULAR SARCOCYSTOSIS

Diagnosis

The diagnostic method depends on the clinical form.

For intestinal disease:

Parasitologic examination of stool specimens

may identify:

Oocysts or sporocysts

Stool Examination

Stool microscopy is primarily useful for:

Intestinal sarcocystosis

Detection of characteristic parasitic stages supports the diagnosis.

Because shedding may be variable, identification can sometimes be difficult.

Muscle Biopsy

For muscular sarcocystosis:

Muscle biopsy

may demonstrate characteristic:

Sarcocysts within skeletal muscle fibers

These may be found:

Incidentally

in otherwise asymptomatic patients.

Diagnostic Pattern

Intestinal disease

→ Stool parasitology

Muscular disease

→ Muscle biopsy

Histopathology

Muscle tissue may contain:

Elongated or cyst-like sarcocysts

containing numerous organisms.

Inflammatory changes may be minimal in incidental infections but can become more prominent in symptomatic:

Sarcocystis-associated myositis

Sarcocystis vs. Cystoisospora belli

Both belong to the broader group of:

Coccidian protozoa

However, their clinical patterns differ.

Sarcocystis

→ Raw meat exposure may cause intestinal disease

→ Can form sarcocysts in skeletal muscle

→ Muscular sarcocystosis possible

Cystoisospora belli

→ Fecal–oral transmission

→ Primarily causes watery diarrhea

→ Particularly important in immunocompromised patients

Sarcocystis vs. Trichinella

Both can produce:

Muscle symptoms after parasitic infection

but their clinical patterns differ.

Sarcocystis

→ Intestinal or muscular sarcocystosis

→ Muscle cysts may be incidental

→ Myalgia and muscle swelling possible

Trichinella

→ Raw/undercooked pork or wild game

→ Intestinal symptoms followed by systemic larval migration

→ Myalgia + fever + eosinophilia + periorbital edema are classic

High-Yield Distinction

Myalgia + eosinophilia + periorbital edema after undercooked pork/wild game

→ Think Trichinella

Sarcocysts demonstrated directly within skeletal muscle

→ Think Sarcocystis

Treatment of Intestinal Infection

The source states that treatment is:

Usually unnecessary

for gastrointestinal infection.

This reflects the generally:

Mild and self-limited

nature of intestinal sarcocystosis.

Supportive Care

If gastrointestinal symptoms occur, management may include:

• Oral hydration

• Electrolyte replacement when necessary

• Symptomatic treatment

Specific antiparasitic therapy is generally not required for uncomplicated intestinal disease.

Treatment of Muscular Sarcocystosis

The source notes that:

Metronidazole

has been used for:

Myositis

However, evidence for specific antiparasitic therapy in muscular sarcocystosis is limited, and treatment is generally individualized according to disease severity.

Prevention

Prevention of intestinal sarcocystosis centers on:

Proper cooking of meat

particularly:

Beef and pork

Food Safety

Avoid:

• Raw beef

• Undercooked beef

• Raw pork

• Undercooked pork

Adequate cooking destroys viable tissue cysts and reduces transmission.

Environmental Prevention

Because muscular sarcocystosis may result from ingestion of environmentally contaminated material, general preventive measures include:

• Safe drinking water

• Appropriate food hygiene

• Handwashing

• Prevention of fecal contamination of food and water

High-Yield Clinical Pattern

Intestinal Disease

Raw beef/pork

• ●

Mild gastrointestinal illness

• ●

Sporocysts in stool

→ SARCOCYSTIS

Muscular Disease

Southeast Asian exposure

• ●

Myalgia + muscle swelling

• ●

Eosinophilia

• ●

Sarcocysts on muscle biopsy

→ MUSCULAR SARCOCYSTOSIS

Exam Essentials

Genus: Sarcocystis

Organism: Protozoan parasite

Group: Coccidian protozoa

Distribution: Worldwide

Important geographic association: Southeast Asia

Incubation: Unclear

Major disease forms: Intestinal and muscular sarcocystosis

S. bovihominis: Associated with cattle/beef

S. suihominis: Associated with pigs/pork

Intestinal infection: Usually mild or asymptomatic

Human role in intestinal disease: Definitive host

Transmission: Consumption of raw/undercooked meat containing sarcocysts

Diagnosis: Stool parasitology

Muscular infection: Often asymptomatic but may cause myalgia and muscle swelling

Human role in muscular disease: Accidental intermediate host

Important laboratory clue: Eosinophilia may occur

Diagnosis: Muscle biopsy demonstrating sarcocysts

Treatment of uncomplicated intestinal disease: Usually not necessary

Source treatment for myositis: Metronidazole has been used

Prevention: Proper cooking of beef and pork, safe food/water practices

Key clinical pearl: Sarcocystis can cause two distinct human syndromes depending on the host role. Eating raw or undercooked infected beef (S. bovihominis) or pork (S. suihominis) makes humans definitive hosts and produces usually mild intestinal disease, whereas accidental acquisition of sporocysts can make humans intermediate hosts, producing sarcocysts in skeletal muscle with possible myalgia, swelling, and eosinophilia.

Infectious Disease and Microbiology – Saksenaea vasiformis

Overview

Saksenaea vasiformis is an uncommon filamentous mold belonging to the group of fungi that cause mucormycosis, historically termed zygomycosis. Microscopically, it produces broad, hyaline, sparsely septate or nonseptate hyphae.

Unlike the classic rhinocerebral mucormycosis associated with severe immunocompromise or uncontrolled diabetes, S. vasiformis is particularly notable for causing cutaneous and subcutaneous infection in otherwise immunocompetent individuals following traumatic inoculation.

Classification

Genus: Saksenaea

Species: Saksenaea vasiformis

Historically, infections caused by this organism were classified as:

Zygomycosis

The preferred modern terminology is:

Mucormycosis

Microbiologic Characteristics

S. vasiformis is:

• A filamentous fungus (mold)

• Characterized by hyaline hyphae

• Broad and ribbon-like

• Sparsely septate or nonseptate

• A member of the Mucorales

These microscopic characteristics resemble other fungi responsible for mucormycosis.

High-Yield Microbiology Pattern

Broad hyaline mold

• ●

Pauciseptate/nonseptate hyphae

• ●

Traumatic inoculation

• ●

Rapidly progressive cutaneous infection

→ Think Saksenaea vasiformis

Epidemiology

S. vasiformis is an:

Environmental fungus

Human infection is uncommon.

The most important route of acquisition is:

TRAUMATIC INOCULATION

of fungal elements into:

Skin and subcutaneous tissue

Traumatic Inoculation

Infection may follow disruption of the skin by:

• Penetrating trauma

• Soil-contaminated wounds

• Plant material

• Motor vehicle or other traumatic injuries

• Other environmental inoculation events

This provides direct access to deeper tissues.

Important Host Feature

A particularly important characteristic of Saksenaea infection is that:

Immunocompetent individuals can develop disease

following traumatic inoculation.

This contrasts with many other forms of invasive mucormycosis, which are strongly associated with:

• Uncontrolled diabetes mellitus

• Diabetic ketoacidosis

• Neutropenia

• Hematologic malignancy

• Transplantation

• Major immunosuppression

High-Yield Epidemiologic Pattern

Previously healthy person

• ●

Traumatic wound contaminated with soil

• ●

Progressive necrotic skin/soft-tissue infection

→ Consider Saksenaea vasiformis

Pathogenesis

After traumatic inoculation:

Fungal spores enter damaged tissue

↓

Germination

↓

Broad hyphae invade surrounding tissue

↓

Potential invasion of blood vessels

↓

Vascular thrombosis

↓

Tissue ischemia

↓

Necrosis

This tendency toward vascular invasion is an important feature of:

Mucormycosis

Angioinvasion

Mucorales can invade:

Blood vessel walls

producing:

Thrombosis + infarction + tissue necrosis

This explains why affected tissue may become:

Dark, ischemic, or necrotic

and why antifungal therapy alone may be insufficient in advanced disease.

Clinical Infections

The source describes S. vasiformis as a cause of mucormycosis involving:

• Skin

• Subcutaneous tissue

• Bone

• Lungs

• Rhinocerebral structures

The most characteristic presentation is:

Cutaneous/subcutaneous mucormycosis after trauma

Cutaneous Mucormycosis

Cutaneous infection may begin around the:

Site of traumatic inoculation

and progress to:

• Pain

• Swelling

• Erythema

• Induration

• Ulceration

• Tissue necrosis

Severe infection may extend into:

Fascia + muscle + bone

High-Yield Cutaneous Pattern

Trauma

↓

Contaminated wound

↓

Progressive soft-tissue infection

↓

Necrosis

↓

Broad pauciseptate hyphae on tissue examination

→ Saksenaea mucormycosis

Subcutaneous Infection

The organism may produce infection involving:

Subcutaneous tissues

Disease can remain localized initially but may extend progressively into deeper structures if untreated.

Bone Infection

Extension into bone can produce:

Osteomyelitis

This may occur through:

Direct extension from an infected traumatic wound

or less commonly through disseminated infection.

Pulmonary Infection

S. vasiformis can occasionally cause:

Pulmonary mucormycosis

Pulmonary involvement is less characteristic than traumatic cutaneous disease but can be severe.

Manifestations may include:

• Fever

• Cough

• Dyspnea

• Chest pain

• Pulmonary infiltrates or nodules

• Tissue necrosis

Rhinocerebral Disease

The source also describes:

Rhinocerebral mucormycosis

as a possible manifestation.

This syndrome involves progressive infection of structures such as the:

Nasal cavity → paranasal sinuses → orbit → intracranial structures

although this is less characteristic for Saksenaea than for some other Mucorales.

Diagnosis

Diagnosis is based on:

Histopathology

and

Culture

Because mucormycosis can progress rapidly, tissue examination is particularly important.

Histopathology

Tissue typically demonstrates:

Broad

• ●

Hyaline

• ●

Ribbon-like

• ●

Pauciseptate or nonseptate hyphae

Hyphae may show:

Irregular, often wide-angle branching

High-Yield Histopathology Pattern

Broad ribbon-like hyphae

• ●

Few or no septa

• ●

Wide/irregular-angle branching

• ●

Tissue necrosis and vascular invasion

→ MUCORMYCOSIS

Culture

Culture should be attempted for organism identification.

However, Saksenaea can be:

Difficult to sporulate under routine laboratory conditions

which may complicate conventional morphologic identification.

Therefore, compatible histopathology can be extremely important when culture identification is delayed or difficult.

Saksenaea vs. Aspergillus

Both can cause invasive mold infections, but their morphology differs significantly.

Saksenaea / Mucorales

→ Broad hyphae

→ Pauciseptate or nonseptate

→ Irregular/wide-angle branching

Aspergillus

→ Narrower septate hyphae

→ Regular dichotomous branching

→ Classically approximately 45° branching

Classic Exam Comparison

Broad + nonseptate/pauciseptate + wide-angle

→ Mucorales

Narrow + septate + acute-angle branching

→ Aspergillus

Saksenaea vs. Rhizopus

Both are members of the:

Mucorales

and both produce broad, sparsely septate hyphae.

However:

Saksenaea

→ Particularly associated with traumatic cutaneous/subcutaneous infection

→ Can infect immunocompetent individuals

Rhizopus

→ Classic association with rhinocerebral mucormycosis

→ Strong association with diabetic ketoacidosis and severe immunocompromise

Treatment

The source recommends:

Intravenous amphotericin B

for treatment.

In modern management of invasive mucormycosis, a lipid formulation such as:

Liposomal amphotericin B

is generally an important first-line systemic therapy.

Posaconazole

The source lists:

Posaconazole

as an additional treatment.

It may have an important role in selected cases, including situations requiring alternative or step-down therapy, depending on clinical circumstances and susceptibility.

Surgical Debridement

A critical component of management that accompanies antifungal therapy is:

AGGRESSIVE SURGICAL DEBRIDEMENT

when feasible.

This is especially important in:

Necrotic cutaneous and soft-tissue mucormycosis

because thrombosed blood vessels and devitalized tissue may limit penetration of systemic antifungal therapy.

High-Yield Treatment Principle

Saksenaea mucormycosis

→ Liposomal amphotericin B

• ●

Early aggressive surgical debridement

• ●

Control underlying predisposing factors

→ Consider active azole therapy such as posaconazole in appropriate circumstances

Why Surgery Is Important

Angioinvasion causes:

Thrombosis

↓

Poor blood flow

↓

Necrotic tissue

↓

Reduced delivery of systemic antifungal medication

Therefore:

Removing devitalized infected tissue is often essential.

Repeated debridement may be necessary in extensive disease.

Prevention

There is no vaccine.

General prevention includes:

• Prompt cleaning of traumatic wounds

• Removal of contaminated foreign material

• Appropriate management of soil-contaminated injuries

• Early evaluation of progressive wound necrosis

• Careful wound management after major trauma

High-Yield Clinical Pattern

Immunocompetent patient

• ●

Traumatic inoculation with soil/environmental material

• ●

Rapidly progressive necrotic skin or subcutaneous infection

• ●

Broad pauciseptate/nonseptate hyphae

→ Think SAKSENAEA VASIFORMIS

Exam Essentials

Genus: Saksenaea

Species: S. vasiformis

Organism: Filamentous fungus (mold)

Group: Mucorales

Historical disease term: Zygomycosis

Modern disease term: Mucormycosis

Hyphae: Broad, hyaline, sparsely septate/nonseptate

Branching: Irregular, often wide-angle

Major transmission route: Traumatic inoculation

Important host clue: Can infect immunocompetent individuals

Classic syndrome: Cutaneous/subcutaneous mucormycosis after trauma

Other sites: Bone, lung, and rhinocerebral structures

Major pathogenic mechanism: Angioinvasion → thrombosis → tissue necrosis

Diagnosis: Histopathology + culture

Laboratory issue: May sporulate poorly in routine culture

Source treatment: IV amphotericin B

Preferred amphotericin approach in invasive mucormycosis: Often liposomal amphotericin B

Additional source treatment: Posaconazole

Major management principle: Early antifungal therapy + aggressive surgical debridement

Key clinical pearl: Saksenaea vasiformis is a Mucorales mold distinguished clinically by its ability to cause severe cutaneous or subcutaneous mucormycosis after traumatic environmental inoculation, even in immunocompetent people. A rapidly progressive necrotic wound with broad, ribbon-like, pauciseptate hyphae should prompt urgent consideration of mucormycosis, with early amphotericin B-based therapy and aggressive surgical debridement.

Infectious Disease and Microbiology – Saccharomyces cerevisiae

Overview

Saccharomyces cerevisiae is a rapidly growing yeast with a worldwide distribution. It is best known as baker’s and brewer’s yeast because of its extensive use in baking, brewing, fermentation, and biotechnology.

Historically, S. cerevisiae was considered essentially nonpathogenic. However, it is now recognized as an uncommon opportunistic pathogen, particularly in immunocompromised or critically ill patients and in individuals with central venous catheters. Important infections include fungemia, peritoneal dialysis-associated peritonitis, septic arthritis, respiratory infection, and vaginitis.

Classification

Genus: Saccharomyces

Species: Saccharomyces cerevisiae

Microbiologic Characteristics

S. cerevisiae is:

• A yeast

• Rapid growing

• Usually composed of oval or round budding cells

• Capable of forming pseudohyphal structures under certain conditions

• A facultative organism capable of fermentation

Its ability to ferment carbohydrates explains its widespread use in:

Bread + beer + wine + other fermented products

High-Yield Microbiology Pattern

Rapid-growing budding yeast

• ●

Baker’s/brewer’s yeast

• ●

Usually nonpathogenic

• ●

Opportunistic fungemia in susceptible patients

→ Think Saccharomyces cerevisiae

Epidemiology

S. cerevisiae has a:

Worldwide distribution

It is commonly encountered in:

• Food

• Fermented beverages

• Baking products

• Environmental sources

• Human gastrointestinal and mucosal environments

Because exposure is extremely common while invasive disease is rare, infection usually requires significant:

Host or healthcare-related risk factors

Incubation Period

The incubation period is:

Unknown

Invasive disease usually represents opportunistic infection rather than an acute infection following a predictable exposure.

Opportunistic Pathogenicity

Historically, S. cerevisiae was considered:

Nonpathogenic

However, invasive infections are now well documented.

Disease occurs particularly in patients with:

• Significant immunosuppression

• Malignancy

• Critical illness

• Prolonged hospitalization

• Central venous catheters

• Broad-spectrum antimicrobial exposure

• Disruption of gastrointestinal mucosal barriers

Central Venous Catheter Association

One of the most important manifestations is:

FUNGEMIA

particularly in patients with:

Central venous catheters

Foreign intravascular material can provide a surface for adherence and persistent bloodstream infection.

High-Yield Clinical Pattern

Immunocompromised or critically ill patient

• ●

Central venous catheter

• ●

Blood cultures growing yeast

• ●

Saccharomyces cerevisiae

→ Saccharomyces fungemia

Fungemia

S. cerevisiae can cause true:

Bloodstream infection

Although uncommon, its isolation from blood should not automatically be dismissed as contamination, particularly when:

• Multiple blood cultures are positive

• Fever or sepsis is present

• A central venous catheter is present

• The patient is immunocompromised

• No more likely pathogen explains the illness

Probiotic-Associated Infection

An important clinical association involves probiotic preparations containing:

Saccharomyces boulardii

which is closely related to S. cerevisiae.

Rare cases of:

Saccharomyces fungemia

have occurred in susceptible hospitalized patients receiving or exposed to these yeast-containing probiotic products.

This association is particularly relevant in patients who are:

Critically ill, immunocompromised, or carrying central venous catheters.

High-Yield Probiotic Pattern

Critically ill patient

• ●

Central venous catheter

• ●

Saccharomyces-containing probiotic exposure

• ●

Fungemia

→ Consider invasive Saccharomyces infection

Peritoneal Dialysis-Associated Peritonitis

S. cerevisiae may cause:

Peritonitis

in patients undergoing:

Chronic ambulatory peritoneal dialysis

The peritoneal dialysis catheter can provide:

Portal of entry + foreign surface for persistent infection

High-Yield Dialysis Pattern

Peritoneal dialysis

• ●

Peritonitis

• ●

Yeast isolated from peritoneal fluid

→ Consider Saccharomyces cerevisiae among fungal causes

Septic Arthritis

S. cerevisiae has occasionally been associated with:

Septic arthritis

This represents an uncommon invasive manifestation and requires careful evaluation because recovery of an unusual yeast from a normally sterile joint specimen may represent:

True invasive fungal infection

Respiratory Tract Infection

S. cerevisiae may be recovered from respiratory specimens.

True respiratory infection is uncommon and is most relevant in:

Immunocompromised patients

Because yeast can colonize mucosal surfaces, isolation from respiratory secretions alone does not necessarily establish invasive disease.

Clinical findings, imaging, host factors, and—in selected cases—histopathologic evidence should be considered.

Vaginitis

S. cerevisiae can occasionally cause:

Vaginitis

although:

Candida species

are much more common causes of vulvovaginal yeast infection.

Symptoms may resemble candidal vulvovaginitis, including:

• Vulvar pruritus

• Irritation

• Burning

• Vaginal discharge

Diagnosis

The primary diagnostic method is:

CULTURE

The organism may be recovered from:

• Blood

• Peritoneal fluid

• Synovial fluid

• Respiratory specimens

• Vaginal specimens

• Other appropriate clinical material

Blood Culture Interpretation

Recovery of S. cerevisiae from:

Blood

should receive particular attention.

In a patient with:

Fever + central venous catheter + immunocompromise

the isolate should be evaluated as a potential:

True bloodstream pathogen

rather than automatically classified as a contaminant.

Culture

Culture demonstrates:

Rapidly growing yeast

Laboratory identification is important because Saccharomyces may initially be confused with other clinically relevant yeasts.

Saccharomyces vs. Candida

Both are:

Budding yeasts

and both may be associated with invasive bloodstream infection.

However:

Saccharomyces cerevisiae

→ Baker’s/brewer’s yeast

→ Usually low pathogenicity

→ Invasive infection uncommon

→ May be associated with central venous catheters and probiotic exposure

Candida

→ Much more common human opportunistic yeast

→ Major cause of candidemia

→ Frequently causes mucosal and invasive infections

Saccharomyces vs. Rhodotorula

Saccharomyces

→ Rapid-growing budding yeast

→ Baker’s/brewer’s yeast

→ Opportunistic fungemia

Rhodotorula

→ Characteristic pink, coral, orange, or red pigmentation

→ Strong central-line fungemia association

→ Often initially considered a contaminant

Both can become important opportunistic pathogens in patients with:

Indwelling intravascular devices

Treatment of Systemic Infection

The source recommends:

Intravenous amphotericin B

for:

Systemic infections

Because invasive Saccharomyces disease is uncommon, treatment should be individualized according to:

Disease severity + infection site + susceptibility + host factors

Source Control

For catheter-associated fungemia, an important management principle is:

Evaluate the central venous catheter as the infectious source

Removal of an implicated catheter may be important when clinically appropriate.

Thus:

Antifungal therapy + source control

are key principles in invasive disease.

High-Yield Fungemia Management

Saccharomyces fungemia

→ Active systemic antifungal therapy

• ●

Evaluate/remove implicated central venous catheter when appropriate

• ●

Stop avoidable Saccharomyces-containing probiotic exposure

• ●

Assess for complications of persistent fungemia

Treatment of Vaginitis

For S. cerevisiae-associated vaginitis, the source lists:

Topical azole therapy

Because Candida is a much more common cause of vulvovaginal yeast infection, culture and species identification may become particularly useful in:

Persistent or recurrent atypical cases

Prevention

There is no vaccine against S. cerevisiae infection.

Prevention of healthcare-associated invasive disease centers on:

• Appropriate central-line care

• Removal of unnecessary intravascular devices

• Good hand hygiene

• Appropriate management of immunocompromised patients

• Careful consideration of live yeast-containing probiotics in highly susceptible hospitalized patients

High-Yield Clinical Pattern

Immunocompromised/critically ill patient

• ●

Central venous catheter

• ●

Fungemia

• ●

Rapid-growing baker’s/brewer’s yeast

→ Think SACCHAROMYCES CEREVISIAE

Exam Essentials

Genus: Saccharomyces

Species: S. cerevisiae

Organism: Yeast

Growth: Rapid

Common name: Baker’s/brewer’s yeast

Distribution: Worldwide

Traditional view: Generally nonpathogenic

Modern significance: Rare opportunistic pathogen

Major susceptible hosts: Immunocompromised and critically ill patients

Major device association: Central venous catheter

Major invasive infection: Fungemia

Other infections: Peritoneal dialysis-associated peritonitis, septic arthritis, respiratory infection, and vaginitis

Important additional association: Exposure to Saccharomyces boulardii-containing probiotics in susceptible hospitalized patients

Diagnosis: Culture

Source treatment for systemic infection: IV amphotericin B

Source treatment for vaginitis: Topical azole

Management principle: Systemic antifungal treatment plus source control when an infected catheter or other device is implicated

Key clinical pearl: Saccharomyces cerevisiae is the familiar baker’s and brewer’s yeast and is ordinarily of low pathogenicity, but it can become a true opportunistic pathogen. The classic invasive setting is fungemia in an immunocompromised or critically ill patient with a central venous catheter; yeast-containing probiotic exposure is another important clue. In this setting, the organism should not automatically be dismissed as a contaminant, and systemic antifungal therapy together with appropriate source control should be considered.

Infectious Disease and Microbiology – Rothia dentocariosa

Overview

Rothia dentocariosa is an aerobic, pleomorphic, Gram-positive bacillus that is part of the normal flora of the oral cavity. It is generally considered a low-virulence organism, but it can cause invasive disease under appropriate conditions.

The organism is most strongly associated with dental disease, including dental caries, periodontal infection, and oral abscesses. A particularly important invasive manifestation is infective endocarditis, especially when bacteremia arises from an oral source.

Classification

Genus: Rothia

Species: Rothia dentocariosa

Microbiologic Characteristics

R. dentocariosa is:

• Aerobic

• Gram-positive

• Pleomorphic

• Bacillary or coccobacillary in appearance

Because of its variable morphology, it can sometimes resemble other Gram-positive organisms isolated from the oral cavity.

High-Yield Microbiology Pattern

Pleomorphic Gram-positive bacillus

• ●

Oral flora

• ●

Dental disease

• ●

Endocarditis

→ Think Rothia dentocariosa

Epidemiology

R. dentocariosa has a:

Worldwide distribution

It commonly colonizes the:

Oral cavity

and is therefore encountered in association with:

• Teeth

• Gingiva

• Dental plaque

• Periodontal tissues

Incubation Period

The incubation period is:

Unknown

Because infection usually arises from endogenous oral flora rather than a discrete transmissible exposure, a predictable incubation period is not generally defined.

Dental Caries

R. dentocariosa has been implicated in the pathogenesis of:

Dental caries

Its presence within dental plaque and oral microbial communities supports its association with tooth decay.

Periodontal Disease

The organism may also be associated with:

Periodontal disease

and can participate in infections involving:

• Gingiva

• Periodontal tissues

• Dental structures

Oral and Dental Abscesses

R. dentocariosa may contribute to:

Dental or periodontal abscess formation

especially in the setting of:

• Poor dentition

• Dental caries

• Periodontal disease

• Local disruption of oral tissues

High-Yield Oral Pattern

Poor dentition

• ●

Dental caries or periodontal disease

• ●

Pleomorphic Gram-positive bacillus

→ Consider Rothia dentocariosa

Endocarditis

The most important invasive infection associated with R. dentocariosa is:

INFECTIVE ENDOCARDITIS

Bacteremia may occur after disruption of oral mucosal surfaces, allowing organisms from the oral flora to enter the bloodstream.

Pathogenesis of Endocarditis

A simplified sequence is:

Oral colonization

↓

Dental disease or mucosal disruption

↓

Transient or persistent bacteremia

↓

Adherence to damaged or abnormal cardiac endothelium

↓

Vegetation formation

↓

Infective endocarditis

Risk Factors for Invasive Disease

Invasive infection may be more likely in patients with:

• Poor dental health

• Periodontal disease

• Recent dental manipulation

• Preexisting valvular abnormalities

• Prosthetic cardiac material

• Immunocompromising conditions

High-Yield Endocarditis Pattern

Dental disease

• ●

Subacute endocarditis

• ●

Gram-positive pleomorphic bacillus

→ Think Rothia dentocariosa

Diagnosis

The primary diagnostic method is:

Culture

Relevant specimens may include:

• Blood cultures

• Abscess material

• Tissue specimens

• Oral or dental specimens in selected settings

Blood Cultures

In suspected endocarditis:

Multiple blood cultures

are particularly important.

Repeated isolation from blood strongly supports:

True invasive infection

rather than contamination.

Identification Pitfall

Because Rothia may resemble other Gram-positive organisms morphologically, accurate laboratory identification can sometimes be difficult.

Potential confusion may occur with:

• Corynebacterium species

• Actinomyces species

• Other pleomorphic Gram-positive rods

Modern identification methods may help distinguish these organisms.

Treatment

For endocarditis, the source recommends:

Penicillin

combined with:

An aminoglycoside

Additional Treatment Options

The source also lists:

• Cephalosporins

• Erythromycin

• Aminoglycosides

Antimicrobial selection should ideally be guided by:

Culture and susceptibility testing

especially in invasive disease.

Endocarditis Treatment Principle

Because infective endocarditis represents a deep-seated intravascular infection, management generally requires:

Prolonged antimicrobial therapy

and evaluation for complications such as:

• Valvular destruction

• Embolic events

• Heart failure

• Persistent bacteremia

Role of Aminoglycosides

The source recommends combining:

Penicillin + aminoglycoside

for endocarditis.

The rationale is potential:

Synergistic bactericidal activity

although treatment should ultimately be individualized according to susceptibility, renal function, and modern endocarditis management principles.

Source Control

For dental or periodontal infection, treatment may also require:

• Drainage of abscesses

• Dental treatment

• Removal of infected or nonviable tissue

• Management of underlying periodontal disease

Antibiotics alone may not be sufficient when a localized dental source persists.

Rothia dentocariosa vs. Viridans Streptococci

Both are associated with:

Oral flora

and both may cause:

Subacute infective endocarditis

However:

Rothia dentocariosa

→ Pleomorphic Gram-positive bacillus

Viridans streptococci

→ Gram-positive cocci in chains

Both should raise concern for an:

Oral or dental source

Rothia vs. Corynebacterium

Rothia

→ Oral flora

→ Pleomorphic Gram-positive bacillus

→ Dental disease and endocarditis

Corynebacterium

→ Often skin or mucosal flora

→ Pleomorphic Gram-positive rods

→ Many species are contaminants, although some cause invasive disease

Clinical context and precise laboratory identification are therefore important.

Prevention

There is no specific vaccine.

General preventive measures include:

• Good oral hygiene

• Regular dental care

• Treatment of dental caries

• Management of periodontal disease

• Appropriate dental infection control

Preventing severe dental disease may reduce episodes of bacteremia originating from the oral cavity.

High-Yield Clinical Pattern

Oral flora

• ●

Dental caries/periodontal disease

• ●

Subacute endocarditis

• ●

Pleomorphic Gram-positive bacillus

→ Think ROTHIA DENTOCARIOSA

Exam Essentials

Genus: Rothia

Species: R. dentocariosa

Morphology: Pleomorphic Gram-positive bacillus

Oxygen requirement: Aerobic

Distribution: Worldwide

Normal habitat: Oral cavity

Major local infections: Dental caries, periodontal disease, dental abscesses

Major invasive infection: Endocarditis

Diagnosis: Culture

Source treatment for endocarditis: Penicillin + aminoglycoside

Additional source-listed options: Cephalosporin, erythromycin, aminoglycosides

Management principle: Culture-guided therapy plus treatment of the underlying dental source when present

Key clinical pearl: Rothia dentocariosa is a pleomorphic aerobic Gram-positive bacillus of the oral flora that is associated with dental caries and periodontal infection and can occasionally cause infective endocarditis. When it is repeatedly isolated from blood in a patient with dental disease or valvular abnormalities, it should be considered a true pathogen rather than automatically dismissed as a contaminant.

Infectious Disease and Microbiology – Human Rotavirus

Overview

Rotavirus is a major viral cause of acute gastroenteritis, particularly in infants and young children. Infection typically produces an abrupt combination of fever, vomiting, and profuse watery, nonbloody diarrhea.

The most important complication is dehydration, which can become severe in young children because of rapid gastrointestinal fluid losses. Treatment is primarily supportive with fluid and electrolyte replacement, while vaccination is the most important specific preventive strategy against severe childhood rotavirus disease.

Classification

Group: Rotavirus

Species: Multiple rotavirus types infect humans

Family: Reoviridae

Rotavirus is an:

RNA virus

with a characteristic segmented genome.

Microbiologic Characteristics

Rotavirus is:

• Double-stranded RNA (dsRNA) virus

• Segmented genome

• Nonenveloped

• Icosahedral

• Member of the Reoviridae family

The genome consists of:

11 segments of double-stranded RNA

High-Yield Microbiology Pattern

Nonenveloped virus

• ●

Segmented double-stranded RNA

• ●

11 genome segments

• ●

Infant with watery diarrhea

→ Think ROTAVIRUS

Wheel-Like Appearance

The name:

ROTAVIRUS

comes from the Latin word:

rota = wheel

because viral particles have a characteristic:

Wheel-like appearance

on electron microscopy.

High-Yield Morphology

Wheel-shaped virus

• ●

Segmented dsRNA

• ●

Pediatric gastroenteritis

→ ROTAVIRUS

Incubation Period

The incubation period is usually:

1–3 days

Therefore, gastrointestinal symptoms generally develop rapidly after infection.

Epidemiology

Rotavirus has a:

Worldwide distribution

Clinically significant disease occurs particularly in:

Infants and young children

Although older children and adults can also become infected, disease is generally most clinically important in young children because of their greater vulnerability to:

Severe dehydration

Transmission

Rotavirus is transmitted primarily by the:

Fecal–oral route

Transmission can occur through:

• Contaminated hands

• Contaminated surfaces and objects

• Close person-to-person contact

• Contaminated environmental material

The virus is highly transmissible.

Environmental Stability

Because rotavirus is:

Nonenveloped

it is relatively resistant to environmental conditions compared with many enveloped viruses.

This contributes to transmission in settings involving close contact among young children.

High-Risk Settings

Transmission may occur readily in:

• Households

• Childcare centers

• Pediatric healthcare settings

• Other environments involving close contact among children

Pathogenesis

Rotavirus primarily infects:

Mature enterocytes of the small intestine

leading to intestinal dysfunction.

Mechanism of Diarrhea

A simplified sequence is:

Rotavirus ingestion

↓

Infection of mature small-intestinal enterocytes

↓

Enterocyte injury and dysfunction

↓

Impaired absorption

• ●

Secretory effects

↓

Profuse watery diarrhea

NSP4 Enterotoxin

An important rotavirus protein is:

NSP4

which functions as a:

Viral enterotoxin

It contributes to intestinal secretion and the development of diarrhea.

High-Yield Pathogenesis Pattern

Small-intestinal enterocyte infection

• ●

NSP4 enterotoxin

• ●

Malabsorption and secretion

→ Watery diarrhea

Rotavirus Gastroenteritis

The classic clinical syndrome consists of:

FEVER

• ●

VOMITING

• ●

WATERY NONBLOODY DIARRHEA

This combination is especially characteristic in:

Infants and young children

Vomiting

Vomiting frequently occurs:

Early in the illness

and can contribute substantially to:

Fluid loss

It can also make oral fluid replacement more difficult.

Diarrhea

The diarrhea is typically:

Watery

and:

Nonbloody

The absence of gross blood reflects the primarily noninvasive nature of the intestinal infection.

High-Yield Clinical Pattern

Infant or young child

• ●

Fever

• ●

Vomiting

• ●

Profuse watery nonbloody diarrhea

→ Think ROTAVIRUS GASTROENTERITIS

Dehydration

The most important complication is:

SEVERE DEHYDRATION

This is particularly dangerous in:

Infants and young children

because substantial fluid and electrolyte losses can develop rapidly.

Signs of Dehydration

Clinical findings may include:

• Dry mucous membranes

• Reduced urine output

• Tachycardia

• Reduced tears

• Sunken eyes

• Lethargy

• Poor peripheral perfusion

Severe dehydration may progress to:

Hypovolemic shock

if fluid losses are not corrected.

Diagnosis

Most uncomplicated viral gastroenteritis can be diagnosed clinically.

When specific confirmation of rotavirus is needed, the source lists:

Rotavirus antigen detection in stool

as an important diagnostic method.

Stool Antigen Testing

Rotavirus antigens can be detected directly from:

Stool specimens

using immunologic assays.

This provides relatively rapid identification of the virus.

Molecular Testing

Modern gastrointestinal molecular panels may also detect:

Rotavirus RNA

along with other enteric pathogens.

Testing is generally reserved for situations in which identifying the specific pathogen would alter clinical or infection-control management.

Electron Microscopy

The source also lists:

Direct visualization by electron microscopy

Electron microscopy can demonstrate the characteristic:

Wheel-like viral particles

However, it is not generally required for routine clinical diagnosis.

High-Yield Diagnostic Pattern

Child with watery diarrhea

• ●

Positive rotavirus stool antigen

→ Rotavirus gastroenteritis

Treatment

Treatment is:

SYMPTOMATIC AND SUPPORTIVE

There is:

No routinely used specific antiviral therapy

for rotavirus gastroenteritis.

Oral Rehydration Therapy

The cornerstone of treatment for most patients is:

ORAL REHYDRATION SOLUTION

This replaces:

• Water

• Sodium

• Glucose

• Other electrolytes

and helps prevent progression to severe dehydration.

Severe Dehydration

Patients who cannot maintain adequate oral intake or who develop severe dehydration may require:

Intravenous fluid replacement

The major therapeutic priority is therefore:

Correction of fluid and electrolyte losses

High-Yield Treatment Pattern

Rotavirus

→ No specific routine antiviral

→ Oral rehydration when possible

→ IV fluids if severe dehydration

Antibiotics

Rotavirus is a:

Viral infection

Therefore:

Antibiotics are not indicated

for uncomplicated rotavirus gastroenteritis.

Prevention

The source emphasizes:

• Hand hygiene

• Gloves

particularly when caring for patients with infectious diarrhea.

Additional environmental and contact precautions are important because rotavirus can spread efficiently through:

Fecal contamination

Rotavirus Vaccination

The most important specific preventive measure is:

ROTAVIRUS VACCINATION

Modern rotavirus vaccines are:

Live attenuated oral vaccines

given during:

Early infancy

Vaccination has greatly reduced the burden of severe rotavirus gastroenteritis and hospitalization in vaccinated populations.

High-Yield Prevention Pattern

Infant

→ Oral live rotavirus vaccine

→ Major protection against severe rotavirus gastroenteritis

Rotavirus vs. Norovirus

Both can cause:

Acute viral gastroenteritis

but their classic epidemiologic patterns differ.

Rotavirus

→ Particularly important in infants and young children

→ Severe dehydration is a major concern

→ Segmented dsRNA

→ Vaccine available

Norovirus

→ All age groups

→ Classic cause of outbreaks in cruise ships, institutions, schools, and restaurants

→ Positive-sense ssRNA

→ No routinely used vaccine

Rotavirus vs. Adenovirus

Rotavirus

→ Segmented dsRNA virus

→ Fever + vomiting + watery diarrhea

→ Major cause of pediatric gastroenteritis

Enteric adenovirus

→ dsDNA virus

→ Types 40/41 classically cause pediatric gastroenteritis

→ Diarrhea may be more prolonged

Rotavirus vs. Bacterial Dysentery

Rotavirus

→ Watery, nonbloody diarrhea

→ Primarily noninvasive

Shigella/Campylobacter and other invasive bacterial pathogens

→ May produce bloody or inflammatory diarrhea

→ Fever and abdominal pain may be prominent

High-Yield Clinical Pattern

1–3 day incubation

• ●

Infant/young child

• ●

Fever and vomiting

• ●

Watery nonbloody diarrhea

• ●

Rapid dehydration

→ Think ROTAVIRUS

Exam Essentials

Virus: Rotavirus

Family: Reoviridae

Genome: Double-stranded RNA (dsRNA)

Genome structure: 11 segments

Envelope: Absent

Appearance: Wheel-like on electron microscopy

Incubation: 1–3 days

Distribution: Worldwide

Major host: Infants and young children

Transmission: Fecal–oral

Major disease: Acute gastroenteritis

Classic symptoms: Fever + vomiting + watery nonbloody diarrhea

Major complication: Severe dehydration

Major intestinal target: Mature small-intestinal enterocytes

Enterotoxin: NSP4

Diagnosis when needed: Stool antigen detection or molecular testing

Historical/direct visualization: Electron microscopy

Treatment: Supportive fluid and electrolyte replacement

Specific antiviral: None routinely used

Prevention: Hand hygiene, appropriate contact precautions, and rotavirus vaccination

Vaccine: Live oral vaccine administered during infancy

Key clinical pearl: Rotavirus is a nonenveloped Reoviridae virus with 11 segments of double-stranded RNA and a characteristic wheel-like appearance. It classically causes fever, vomiting, and profuse watery nonbloody diarrhea in infants and young children, with severe dehydration as the major complication. Management centers on rapid oral or intravenous rehydration, while oral rotavirus vaccination is the most important specific preventive measure.

Infectious Disease and Microbiology – Rickettsia Species

Overview

Rickettsia species are small, obligate intracellular coccobacilli responsible for several important arthropod-borne infections. Depending on the species, transmission occurs through ticks, fleas, lice, or mites.

Many rickettsial diseases are characterized by fever, severe headache, rash, and sometimes an inoculation eschar. The organisms preferentially infect vascular endothelial cells, resulting in vasculitis and increased vascular permeability, which account for many systemic manifestations.

Important Species and Diseases

Major organisms traditionally included among the rickettsiae are:

• Rickettsia rickettsii — Rocky Mountain spotted fever

• R. conorii — Mediterranean spotted fever/Boutonneuse fever

• R. australis — Queensland tick typhus

• R. sibirica — North Asian tick typhus

• R. akari — Rickettsialpox

• R. prowazekii — Epidemic/louse-borne typhus

• R. typhi — Murine/flea-borne typhus

Older literature may use:

R. mooseri for R. typhi

and

R. tsutsugamushi / R. orientalis for the organism now classified as Orientia tsutsugamushi, the cause of scrub typhus.

Microbiologic Characteristics

Rickettsiae are:

• Small coccobacilli

• Obligate intracellular bacteria

• Poorly visualized by conventional Gram staining

• Dependent on living host cells for replication

• Frequently transmitted by arthropod vectors

A major cellular target for many Rickettsia species is the:

Vascular endothelium

Pathogenesis

Infection of endothelial cells produces:

Endothelial injury

↓

Small-vessel vasculitis

↓

Increased vascular permeability

↓

Edema + rash + tissue injury

↓

Potential multiorgan disease

This explains why severe rickettsial infections may involve the:

• Skin

• Brain

• Lungs

• Kidneys

• Heart and circulation

High-Yield Microbiology Pattern

Obligate intracellular coccobacillus

• ●

Arthropod exposure

• ●

Endothelial infection/vasculitis

• ●

Fever ± rash ± eschar

→ Think RICKETTSIAL INFECTION

Incubation Period

The incubation period depends on the causative species.

R. rickettsii: approximately 3–14 days

R. conorii: usually 5–7 days

R. sibirica: approximately 2–7 days

R. australis: usually 7–10 days

Rickettsia rickettsii

Rickettsia rickettsii causes:

Rocky Mountain spotted fever (RMSF)

Transmission occurs through:

Tick bites

Rocky Mountain Spotted Fever

Typical manifestations include:

• Fever

• Severe headache

• Myalgia

• Malaise

• Gastrointestinal symptoms

• Rash

The classic rash begins around the:

Wrists and ankles

and spreads toward the:

Trunk

The rash may characteristically involve:

Palms and soles

High-Yield RMSF Pattern

Tick bite

• ●

Fever + severe headache

• ●

Rash beginning at wrists/ankles

• ●

Palms and soles involved

→ Rickettsia rickettsii

Rickettsia conorii

Rickettsia conorii causes:

Boutonneuse fever

also known as:

Mediterranean spotted fever

Older regional terminology includes India tick typhus and African tick typhus.

Clinical Manifestations

Typical findings include:

• Fever

• Primary lesion at the tick-bite site

• Regional lymphadenopathy in some patients

• Generalized maculopapular erythematous rash

The primary lesion may:

Ulcerate

and develop a:

Black necrotic center

Tache Noire

The dark inoculation eschar associated with Mediterranean spotted fever is classically called:

Tache noire

High-Yield R. conorii Pattern

Tick exposure

• ●

Fever

• ●

Black inoculation eschar

• ●

Generalized maculopapular rash

→ Rickettsia conorii

Rickettsia australis

Rickettsia australis causes:

Queensland tick typhus

The clinical manifestations resemble those caused by R. conorii and may include:

• Fever

• Tick-bite lesion/eschar

• Lymphadenopathy

• Maculopapular rash

High-Yield Pattern

Australian exposure

• ●

Tick bite

• ●

Fever + eschar + rash

→ Rickettsia australis

Rickettsia sibirica

Rickettsia sibirica causes:

North Asian tick typhus

or:

North Asian tick fever

Clinical findings resemble Mediterranean spotted fever and may include:

• Fever

• Inoculation eschar

• Regional lymphadenopathy

• Generalized rash

High-Yield Pattern

Northern Asian exposure

• ●

Tick bite

• ●

Eschar + fever + rash

→ Rickettsia sibirica

Rickettsia akari

Rickettsia akari causes:

Rickettsialpox

Unlike many spotted-fever rickettsiae, it is transmitted by:

Mites

Rickettsialpox

Typical manifestations include:

• Fever

• Inoculation lesion/eschar

• Lymphadenopathy

• Disseminated vesicular rash

The rash generally does not involve:

Palms and soles

The vesicular eruption may clinically resemble:

Varicella

High-Yield Rickettsialpox Pattern

Mite bite

• ●

Fever

• ●

Eschar

• ●

Generalized vesicular rash

• ●

Palms/soles usually spared

→ Rickettsia akari

Rickettsia prowazekii

Rickettsia prowazekii causes:

Epidemic typhus

also called:

Louse-borne typhus

or classic:

Typhus fever

Vector

The major vector is the:

Human body louse

Pediculus humanus corporis

Transmission is therefore favored by circumstances involving:

• Crowding

• Body-louse infestation

• Poor access to hygiene

• War or population displacement

Clinical Manifestations

Epidemic typhus typically causes:

• High fever

• Severe headache

• Myalgia

• Marked systemic illness

• Rash

The rash classically begins on the:

Trunk

and spreads toward the extremities.

The:

Palms and soles are usually spared.

High-Yield Epidemic Typhus Pattern

Body lice

• ●

Crowding/displacement

• ●

High fever + headache

• ●

Truncal rash spreading outward

→ Rickettsia prowazekii

Brill-Zinsser Disease

R. prowazekii can persist after primary infection and reactivate years later.

This recurrent form is called:

Brill-Zinsser disease

It is generally milder than primary epidemic typhus but can provide a reservoir for renewed transmission when body lice are present.

Rickettsia typhi

Rickettsia typhi causes:

Murine typhus

also known as:

Endemic typhus

or:

Flea-borne typhus

The historical name:

Rickettsia mooseri

refers to the same organism in older literature.

Vector

Transmission occurs through:

Fleas

The classic epidemiologic cycle involves:

Rodents + fleas

although other flea-associated mammalian cycles can contribute.

Clinical Manifestations

Murine typhus commonly produces:

• Fever

• Headache

• Myalgia

• Malaise

• Rash in some patients

The disease is generally less severe than classic epidemic typhus.

High-Yield Murine Typhus Pattern

Flea exposure

• ●

Rodent-associated environment

• ●

Fever + headache ± rash

→ Rickettsia typhi

Orientia tsutsugamushi

The organism historically called:

Rickettsia tsutsugamushi

or

Rickettsia orientalis

is now:

Orientia tsutsugamushi

It causes:

SCRUB TYPHUS

Vector

Scrub typhus is transmitted by larval trombiculid mites known as:

Chiggers

Clinical Manifestations

Scrub typhus may produce:

• Fever

• Severe headache

• Lymphadenopathy

• Rash

• Eschar at the inoculation site

• Systemic complications in severe disease

High-Yield Scrub Typhus Pattern

Asia-Pacific exposure

• ●

Chigger exposure

• ●

Fever

• ●

Black eschar

→ Orientia tsutsugamushi

Major Vector Associations

Organism

Disease

Vector

R. rickettsii

Rocky Mountain spotted fever

Tick

R. conorii

Mediterranean spotted fever

Tick

R. australis

Queensland tick typhus

Tick

R. sibirica

North Asian tick typhus

Tick

R. akari

Rickettsialpox

Mite

R. prowazekii

Epidemic typhus

Body louse

R. typhi

Murine typhus

Flea

O. tsutsugamushi

Scrub typhus

Chigger

Vector Memory Aid

Spotted fevers

→ TICKS

Epidemic typhus

→ LICE

Murine typhus

→ FLEAS

Rickettsialpox

→ MITES

Scrub typhus

→ CHIGGERS

Diagnosis

The source lists:

Serology

as the principal diagnostic method.

Serologic testing remains important, but antibodies may not yet be detectable during the:

Early phase of illness

Therefore:

An early negative serologic test does not reliably exclude rickettsial disease.

Molecular Diagnosis

Depending on the disease and available laboratory methods:

PCR/NAAT

may help identify rickettsial DNA.

For diseases associated with an:

Eschar

molecular testing of lesion material may sometimes be particularly useful.

Critical Diagnostic Principle

For severe rickettsial infections, especially suspected RMSF:

Treatment should not be delayed while awaiting laboratory confirmation.

Clinical suspicion and epidemiologic exposure are extremely important.

Treatment

The source recommends:

Doxycycline 100 mg orally every 12 hours

for approximately:

7 days

Doxycycline is the principal treatment for most clinically significant rickettsial infections.

Exact duration varies according to the specific disease and clinical response.

High-Yield Treatment Rule

Suspected rickettsial disease

→ DOXYCYCLINE

For suspected:

Rocky Mountain spotted fever

→ Start treatment immediately

→ Do not wait for serologic confirmation

Doxycycline in Children

An important clinical principle is that doxycycline is also recommended for suspected:

Rocky Mountain spotted fever in children

when clinically indicated.

Potential concern about tooth staining should not delay appropriate treatment of this potentially life-threatening infection.

Chloramphenicol

The source lists:

Chloramphenicol

as an additional treatment option.

It has historically been used as an alternative for certain rickettsial diseases, although doxycycline is generally preferred.

Prevention

The primary preventive strategy is:

Avoidance of arthropod bites

Tick Prevention

Important measures include:

• Protective clothing

• Appropriate insect repellents

• Avoiding heavily tick-infested vegetation when possible

• Checking the skin after outdoor exposure

• Prompt removal of attached ticks

Louse and Flea Prevention

Additional measures include:

• Personal hygiene

• Control of body-louse infestation

• Appropriate washing of clothing and bedding

• Flea control

• Rodent control where appropriate

High-Yield Rash Comparison

Rocky Mountain Spotted Fever

Wrists/ankles → trunk

Palms and soles may be involved

Epidemic Typhus

Trunk → extremities

Palms and soles usually spared

Rickettsialpox

Vesicular eruption

Palms and soles generally spared

Mediterranean Spotted Fever

Maculopapular rash

• ●

Tache noire/eschar

High-Yield Clinical Pattern

Arthropod exposure

• ●

Acute fever and severe headache

• ●

Rash and/or eschar

• ●

Intracellular coccobacillus

→ Think RICKETTSIAL DISEASE

Exam Essentials

Genus: Rickettsia

Morphology: Small coccobacillus

Lifestyle: Obligate intracellular

Major cellular target: Vascular endothelial cells

Major pathogenesis: Vasculitis

Transmission: Primarily ticks, fleas, lice, or mites

Diagnosis: Serology, with PCR useful in selected circumstances

Early serology: May be negative

Treatment: Doxycycline

Alternative in source: Chloramphenicol

Critical treatment rule: Do not delay doxycycline in suspected severe rickettsial disease while awaiting testing

Prevention: Avoid arthropod bites

R. rickettsii → RMSF → tick + palms/soles rash

R. conorii → Mediterranean spotted fever → tick + tache noire

R. australis → Queensland tick typhus → tick

R. sibirica → North Asian tick typhus → tick

R. akari → Rickettsialpox → mite + vesicular rash

R. prowazekii → Epidemic typhus → body louse

R. typhi → Murine typhus → flea

Orientia tsutsugamushi → Scrub typhus → chigger + eschar

Key clinical pearl: Rickettsial infections are best organized by their arthropod vectors and characteristic skin findings. Most spotted-fever infections are tick-borne; R. prowazekii is louse-borne, R. typhi is flea-borne, R. akari is mite-borne, and Orientia tsutsugamushi is transmitted by chiggers. Because early serology may be negative and delayed treatment can be dangerous—particularly in Rocky Mountain spotted fever—doxycycline should be started promptly when the clinical suspicion is high.